drugset / Trial / NCT00005864

Chloroquinoxaline Sulfonamide in Treating Patients With Stage IV Colorectal Cancer

NCT00005864 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of chloroquinoxaline sulfonamide in treating patients who have stage IV colorectal cancer.

Timeline

Start
2000-04
Primary completion
—
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject CHLORSULFAQUINOXALINE Small molecule — Intravenous

Indications